{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:34:29Z","timestamp":1792946069198,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jacadv.2026.103308","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:51:44Z","timestamp":1791417104000},"page":"103308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Projected Impact of LDL-C and HbA1c Control on Cardiovascular Outcomes in ASCVD and Diabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Hridhay","family":"Karthikeyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6652-9431","authenticated-orcid":false,"given":"Wenjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafeesa","family":"Dhalwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1102-7324","authenticated-orcid":false,"given":"Nathan D.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jacadv.2026.103308_bib1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jacadv.2026.103308_bib2","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2019.09.025","article-title":"Ischemic event rates in very-high-risk adults","volume":"74","author":"Colantonio","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103308_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107767","article-title":"Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease","volume":"35","author":"Zhao","year":"2021","journal-title":"J Diabetes Complications"},{"issue":"4","key":"10.1016\/j.jacadv.2026.103308_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2019.05.035","article-title":"Control of cardiovascular risk factors among US adults with type 2 diabetes with and without cardiovascular disease","volume":"124","author":"Andary","year":"2019","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103308_bib5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/dom.13625","article-title":"Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: the Diabetes Collaborative Registry","volume":"21","author":"Fan","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103308_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/dc15-2439","article-title":"Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the Atherosclerosis Risk in Communities study, multi-ethnic study of atherosclerosis, and Jackson heart study","volume":"39","author":"Wong","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jacadv.2026.103308_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2015.06.019","article-title":"Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial","volume":"66","author":"Bittner","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jacadv.2026.103308_bib9","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacadv.2026.103308_bib10","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jacadv.2026.103308_bib11","first-page":"S207","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.jacadv.2026.103308_bib12","first-page":"S167","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"25","key":"10.1016\/j.jacadv.2026.103308_bib13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.jacc.2023.04.031","article-title":"Assessment of atherothrombotic risk in patients with type 2 diabetes mellitus","volume":"81","author":"Berg","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26007301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26007301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T15:49:29Z","timestamp":1792943369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26007301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2772963X26007301"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103308","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Projected Impact of LDL-C and HbA1c Control on Cardiovascular Outcomes in ASCVD and Diabetes","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103308"}}